Novo Nordisk Walks a Tightrope: Oral Wegovy Approved as Pipeline Drug Shines, Yet Hack and Rival Pre
The Danish pharmaceutical giant closed the week at €38.03, a modest 2% gain that does little to mask…
Ørsted’s Financial Resilience Shines Amid Political Uncertainty
Ørsted posts strong 2023 results and raises divestment targets, while Denmark’s election puts state’s 50.1% stake up for…